Actinium Pharmaceuticals, Inc. (ATNM)
1.57
+0.19
(+13.77%)
USD |
NYAM |
Oct 22, 15:29
Actinium Pharmaceuticals Price : 1.57 for Oct. 22, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 21, 2026 | 1.38 | 1.409 | 1.33 | 1.38 | 358233.0 |
| Oct 20, 2026 | 1.36 | 1.50 | 1.350 | 1.40 | 901051.0 |
| Oct 19, 2026 | 1.14 | 1.40 | 1.13 | 1.32 | 658396.0 |
| Oct 16, 2026 | 1.09 | 1.15 | 1.05 | 1.13 | 174393.0 |
| Oct 15, 2026 | 0.95 | 1.07 | 0.95 | 1.06 | 143236.0 |
| Oct 14, 2026 | 0.99 | 1.022 | 0.9518 | 0.9746 | 84636.00 |
| Oct 13, 2026 | 1.07 | 1.07 | 0.9955 | 0.9995 | 89252.00 |
| Oct 12, 2026 | 1.09 | 1.09 | 1.029 | 1.06 | 98462.00 |
| Oct 09, 2026 | 1.09 | 1.12 | 1.07 | 1.10 | 105763.0 |
| Oct 08, 2026 | 1.09 | 1.10 | 1.06 | 1.08 | 104871.0 |
| Oct 07, 2026 | 1.08 | 1.12 | 1.05 | 1.07 | 100093.0 |
| Oct 06, 2026 | 1.20 | 1.22 | 1.02 | 1.11 | 439575.0 |
| Oct 05, 2026 | 1.16 | 1.24 | 1.16 | 1.20 | 115026.0 |
| Oct 02, 2026 | 1.15 | 1.19 | 1.12 | 1.17 | 81800.00 |
| Oct 01, 2026 | 1.11 | 1.15 | 1.11 | 1.15 | 90832.00 |
| Sep 30, 2026 | 1.14 | 1.20 | 1.10 | 1.12 | 95130.00 |
| Sep 29, 2026 | 1.17 | 1.17 | 1.14 | 1.14 | 62023.00 |
| Sep 28, 2026 | 1.18 | 1.20 | 1.17 | 1.18 | 75374.00 |
| Sep 25, 2026 | 1.19 | 1.205 | 1.18 | 1.20 | 28418.00 |
| Sep 24, 2026 | 1.19 | 1.25 | 1.18 | 1.19 | 85939.00 |
| Sep 23, 2026 | 1.17 | 1.21 | 1.16 | 1.18 | 130427.0 |
| Sep 22, 2026 | 1.18 | 1.22 | 1.17 | 1.17 | 54493.00 |
| Sep 21, 2026 | 1.24 | 1.24 | 1.166 | 1.20 | 99376.00 |
| Sep 18, 2026 | 1.18 | 1.23 | 1.18 | 1.22 | 146207.0 |
| Sep 17, 2026 | 1.26 | 1.26 | 1.18 | 1.19 | 57025.00 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| ACADIA Pharmaceuticals, Inc. | 20.35 |
| Alnylam Pharmaceuticals, Inc. | 227.29 |
| Anika Therapeutics, Inc. | 20.85 |
| Savara, Inc. | 4.495 |
| Vericel Corp. | 42.59 |
Price Related Metrics
| PE Ratio | 4.401 |
| PS Ratio | 1.399 |
| Price to Book Value | 1.629 |
| Earnings Yield | 22.72% |
| Market Cap | 49.36M |
| Operating PE Ratio | 5.136 |
| Normalized PE Ratio | 4.401 |